Prenatal Alcohol Exposure in Rats Diminishes Postnatal Cxcl16 Chemokine Ligand Brain Expression
Maternal ethanol consumption during pregnancy is one of the main causes of Neurodevelopmental disorders (NDD). Prenatal alcohol exposure (PAE) produces several adverse manifestations. Even low or moderate intake has been associated with long-lasting behavioral and cognitive impairment in offspring....
| Published in: | Brain Sciences |
|---|---|
| Main Authors: | Pedro Juárez-Rodríguez, Marisol Godínez-Rubí, Carolina Guzmán-Brambila, Edgar Padilla-Velarde, Arturo Orozco-Barocio, Daniel Ortuño-Sahagún, Argelia E. Rojas-Mayorquín |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-12-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-3425/10/12/987 |
Similar Items
CXCL17: The Black Sheep in the Chemokine Flock
by: Stepan S. Denisov
Published: (2021-07-01)
by: Stepan S. Denisov
Published: (2021-07-01)
Interactions of the chemokines CXCL11 and CXCL12 in human tumor cells
by: Christian Koch, et al.
Published: (2022-12-01)
by: Christian Koch, et al.
Published: (2022-12-01)
Expression and regulation of the CXCL9-11 chemokines and CXCR3 receptor in Atlantic salmon (Salmo salar)
by: Natalia Valdés, et al.
Published: (2024-09-01)
by: Natalia Valdés, et al.
Published: (2024-09-01)
Differential Anti-Tumor Effects of IFN-Inducible Chemokines CXCL9, CXCL10, and CXCL11 on a Mouse Squamous Cell Carcinoma Cell Line
by: Ari Matsumoto, et al.
Published: (2023-04-01)
by: Ari Matsumoto, et al.
Published: (2023-04-01)
CXCL8 – The first chemokine
by: Marco eBaggiolini
Published: (2015-06-01)
by: Marco eBaggiolini
Published: (2015-06-01)
The Chemokine CXCL14 as a Potential Immunotherapeutic Agent for Cancer Therapy
by: Nicholas S. Giacobbi, et al.
Published: (2024-02-01)
by: Nicholas S. Giacobbi, et al.
Published: (2024-02-01)
The effect of transplantation of cultured autologous melanocytes on CXCL9, CXCL10 and CXCL11 expressions in vitiligo
by: Chen Xu, et al.
Published: (2023-01-01)
by: Chen Xu, et al.
Published: (2023-01-01)
Clinical significance of serum CXCL9, CXCL10, and CXCL11 in patients with lupus nephritis
by: Shuo Wang, et al.
Published: (2024-08-01)
by: Shuo Wang, et al.
Published: (2024-08-01)
Pathophysiological role of chemokine MIG/CXCL9 in the development of atopic dermatitis
by: I. V. Kibalina, et al.
Published: (2022-05-01)
by: I. V. Kibalina, et al.
Published: (2022-05-01)
Plasmacytoid Dendritic Cells Depletion and Elevation of IFN-γ Dependent Chemokines CXCL9 and CXCL10 in Children With Multisystem Inflammatory Syndrome
by: Francesca Caldarale, et al.
Published: (2021-03-01)
by: Francesca Caldarale, et al.
Published: (2021-03-01)
Biomarker Significance of Serum CXCL8, CXCL10 and CXCL16 in Breast Tumors of Iraqi Patients
by: Aseel F Khalaf, et al.
Published: (2020-03-01)
by: Aseel F Khalaf, et al.
Published: (2020-03-01)
The Clinical Significance and Role of CXCL1 Chemokine in Gastrointestinal Cancers
by: Jan Korbecki, et al.
Published: (2023-05-01)
by: Jan Korbecki, et al.
Published: (2023-05-01)
The chemokine CXCL13 in lung cancers associated with environmental polycyclic aromatic hydrocarbons pollution
by: Gui-Zhen Wang, et al.
Published: (2015-11-01)
by: Gui-Zhen Wang, et al.
Published: (2015-11-01)
Testosterone Inhibits Secretion of the Pro-Inflammatory Chemokine CXCL1 from Astrocytes
by: Malgorzata Turniak-Kusy, et al.
Published: (2024-03-01)
by: Malgorzata Turniak-Kusy, et al.
Published: (2024-03-01)
CXCL10 Chemokine: A Critical Player in RNA and DNA Viral Infections
by: Noha Mousaad Elemam, et al.
Published: (2022-11-01)
by: Noha Mousaad Elemam, et al.
Published: (2022-11-01)
Targeting CXCL1 chemokine signaling for treating cisplatin ototoxicity
by: Raheem F. H. Al Aameri, et al.
Published: (2023-03-01)
by: Raheem F. H. Al Aameri, et al.
Published: (2023-03-01)
Computational Study of C-X-C Chemokine Receptor (CXCR)3 Binding with Its Natural Agonists Chemokine (C-X-C Motif) Ligand (CXCL)9, 10 and 11 and with Synthetic Antagonists: Insights of Receptor Activation towards Drug Design for Vitiligo
by: Giovanny Aguilera-Durán, et al.
Published: (2020-09-01)
by: Giovanny Aguilera-Durán, et al.
Published: (2020-09-01)
SDF-1/CXCL12: A chemokine in the life cycle of HIV
by: Fernando eArenzana-Seisdedos
Published: (2015-06-01)
by: Fernando eArenzana-Seisdedos
Published: (2015-06-01)
The synergized diagnostic value of VTQ with chemokine CXCL13 in lung tumors
by: Xu Zhang, et al.
Published: (2023-03-01)
by: Xu Zhang, et al.
Published: (2023-03-01)
Chemokine CXCL13–CXCR5 signaling in neuroinflammation and pathogenesis of chronic pain and neurological diseases
by: Kaige Zheng, et al.
Published: (2024-10-01)
by: Kaige Zheng, et al.
Published: (2024-10-01)
Antimicrobial Activity of Chemokine CXCL10 for Dermal and Oral Microorganisms
by: Grant O. Holdren, et al.
Published: (2014-10-01)
by: Grant O. Holdren, et al.
Published: (2014-10-01)
The Chemokine CXCL7 is Correlated with LDH-A and Predicts the Prognosis of Patients with Colorectal Cancer
by: Hai Liang, et al.
Published: (2024-04-01)
by: Hai Liang, et al.
Published: (2024-04-01)
Role of Chemokines in Thyroid Cancer Microenvironment: Is CXCL8 the Main Player?
by: Mario Rotondi, et al.
Published: (2018-06-01)
by: Mario Rotondi, et al.
Published: (2018-06-01)
The Value of CXCL1, CXCL2, CXCL3, and CXCL8 as Potential Prognosis Markers in Cervical Cancer: Evidence of E6/E7 from HPV16 and 18 in Chemokines Regulation
by: Leonardo Fernandez-Avila, et al.
Published: (2023-09-01)
by: Leonardo Fernandez-Avila, et al.
Published: (2023-09-01)
Phytochemicals from Cactaceae family for cancer prevention and therapy
by: Arturo Orozco-Barocio, et al.
Published: (2024-10-01)
by: Arturo Orozco-Barocio, et al.
Published: (2024-10-01)
Disease modification and symptom relief in osteoarthritis using a mutated GCP‐2/CXCL6 chemokine
by: Sara Caxaria, et al.
Published: (2022-12-01)
by: Sara Caxaria, et al.
Published: (2022-12-01)
The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner
by: Victoria Callahan, et al.
Published: (2021-06-01)
by: Victoria Callahan, et al.
Published: (2021-06-01)
The Roles of C-X-C Motif Chemokine Ligand 10 (CXCL10) in Dengue
by: Siti Noraihan Khamis, et al.
Published: (2022-09-01)
by: Siti Noraihan Khamis, et al.
Published: (2022-09-01)
Protection mediated by chemokine CXCL10 in BALB/c mice infected by Leishmania infantum
by: Webertty Mayk Eufrásio Figueiredo, et al.
by: Webertty Mayk Eufrásio Figueiredo, et al.
Immunohistochemical expression of chemokine receptor CXCR3 and its ligand CXCL 11 in basal cell carcinoma
by: Mariya K Ansari, et al.
Published: (2023-01-01)
by: Mariya K Ansari, et al.
Published: (2023-01-01)
The CSF Levels of Neutrophil‐Related Chemokines in Patients with Neuromyelitis Optica
by: Zhuhe Liu, et al.
Published: (2020-07-01)
by: Zhuhe Liu, et al.
Published: (2020-07-01)
Chemokine CXCL14 is associated with prognosis in patients with colorectal carcinoma after curative resection
by: Zeng Jun, et al.
Published: (2013-01-01)
by: Zeng Jun, et al.
Published: (2013-01-01)
Interleukin-8, CXCL10, CXCL11 and their role in insulin resistance in adult females with subclinical hypothyroidism and prediabetes
by: Roxana Adriana Stoica, et al.
Published: (2022-06-01)
by: Roxana Adriana Stoica, et al.
Published: (2022-06-01)
Expression of chemokine CXCL5 and programme death ligand 1 in colorectal cancer tissues are associated with prognosis of patients
by: LIU Shiguang, ZHAO Jingkun, LU Aiguo, MAO Zhihai
Published: (2021-11-01)
by: LIU Shiguang, ZHAO Jingkun, LU Aiguo, MAO Zhihai
Published: (2021-11-01)
Inhibition of nitric oxide synthase activity and chemokine (CXCL12) supplementation can improve hematopoietic reconstitution in mice lethally irradiated by 60Co gamma radiation
by: Daniel Perez Vieira, et al.
Published: (2019-01-01)
by: Daniel Perez Vieira, et al.
Published: (2019-01-01)
Transcriptomic signatures of cold acclimated adipocytes reveal CXCL12 as a Brown autocrine and paracrine chemokine
by: Marina Agueda-Oyarzabal, et al.
Published: (2025-03-01)
by: Marina Agueda-Oyarzabal, et al.
Published: (2025-03-01)
Regulation of cancer stem cells by CXCL1, a chemokine whose secretion is controlled by MCM2
by: Yeon-Jee Kahm, et al.
Published: (2024-03-01)
by: Yeon-Jee Kahm, et al.
Published: (2024-03-01)
CXCR3 chemokine receptor ligands in sarcoidosis
by: N. M. Lazareva, et al.
Published: (2021-03-01)
by: N. M. Lazareva, et al.
Published: (2021-03-01)
Chemokine CXCL13 in serum, CSF and blood–CSF barrier function: evidence of compartment restriction
by: Georg Pilz, et al.
Published: (2020-02-01)
by: Georg Pilz, et al.
Published: (2020-02-01)
Platelet-Derived Chemokine CXCL7 Dimer Preferentially Exists in the Glycosaminoglycan-Bound Form: Implications for Neutrophil–Platelet Crosstalk
by: Aaron J. Brown, et al.
Published: (2017-10-01)
by: Aaron J. Brown, et al.
Published: (2017-10-01)
Similar Items
-
CXCL17: The Black Sheep in the Chemokine Flock
by: Stepan S. Denisov
Published: (2021-07-01) -
Interactions of the chemokines CXCL11 and CXCL12 in human tumor cells
by: Christian Koch, et al.
Published: (2022-12-01) -
Expression and regulation of the CXCL9-11 chemokines and CXCR3 receptor in Atlantic salmon (Salmo salar)
by: Natalia Valdés, et al.
Published: (2024-09-01) -
Differential Anti-Tumor Effects of IFN-Inducible Chemokines CXCL9, CXCL10, and CXCL11 on a Mouse Squamous Cell Carcinoma Cell Line
by: Ari Matsumoto, et al.
Published: (2023-04-01) -
CXCL8 – The first chemokine
by: Marco eBaggiolini
Published: (2015-06-01)
